Australian Clinical Labs Ltd ( (AU:ACL) ) has provided an update.
Allan Gray Australia Pty Ltd has become a substantial holder in Australian Clinical Labs Limited, acquiring a 5.01% voting power through ordinary shares. This development indicates a significant investment interest in the company, potentially impacting its market positioning and signaling confidence in its future prospects.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Limited operates in the healthcare industry, focusing on providing pathology services across Australia. The company offers a range of diagnostic services, including clinical pathology and medical testing, catering to both individual and corporate clients.
YTD Price Performance: -12.50%
Average Trading Volume: 735,881
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$608.1M
For detailed information about ACL stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com